The University of Arizona
Institutional Knowledge Map (KMap)
Picture of Sangeetha Murugapandian

Sangeetha Murugapandian

Associate Clinical Professor, Medicine - (Clinical Series Track)

Medicine
Map Page
10+ Collaborators
$0 / $25.2K Funding
10+ Publications

Research Area

high-risk patients, monoclonal antibody, covid-19, infective endocarditis, extracorporeal membrane oxygenation, continuous renal replacement therapy, patient outcome, epidemiology, glomerular disease, renal biopsy

    Chart
    Bar chart with 7 bars.
    The chart has 1 X axis displaying Year.
    The chart has 1 Y axis displaying values. Data ranges from 1 to 4.
    End of interactive chart.
    Recent

    Viral Nephropathies: Core Curriculum 2024

    2024
    kidney diseases, virology

    Pleural Effusion in a Patient on Peritoneal Dialysis

    2024
    pleural effusion, peritoneal dialysis, patient care, renal failure, fluid management

    The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era

    2023
    covid-19, antiviral, hospitalizations, high-risk patients, omicron variant

    Contemporary Monoclonal Antibody Utilization in Glomerular Diseases

    2023
    monoclonal antibodies, glomerular diseases, contemporary medicine, immunotherapy, nephrology

    CRT-700.23 Short- and Medium-Term Mortality in ESRD Patients Undergoing MitraCliTherapy a Multicenter Retrospective Cohort Study

    2023
    mortality, esrd

    Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era

    2023
    monoclonal antibody, sars-cov-2 omicron, high-risk patients, viral subvariants, antibody effectiveness

    Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 Delta Variant) Infection

    2022
    monoclonal antibody, covid-19, treatment effectiveness, b.1.617.2 delta variant, high-risk patients

    Glucose-Lowering Medications and Cardiovascular outcomes

    2021
    diabetes, cardiovascular, medications, glucose, outcomes

    Drug-coated balloon in peripheral artery disease

    2019
    peripheral artery disease, drug-coated balloon, vascular interventions, medical devices

    Outcomes of patients with atrial fibrillation undergoing percutaneous coronary intervention analysis of national inpatient sample

    2019
    atrial fibrillation, percutaneous coronary intervention, patient outcomes, national inpatient sample, analysis

    Page 1 of 3
    Sangeetha Murugapandian | KMap Profile - Institutional Knowledge Map (KMap)